AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Assura PLC

Pre-Annual General Meeting Information Jun 12, 2020

4924_agm-r_2020-06-12_9b11b2ab-e3d2-469f-996c-b0590ea5c4e3.html

Pre-Annual General Meeting Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 8412P

Assura PLC

12 June 2020

12 June 2020

Assura plc

Amended Notice of AGM

Assura announces that it is posting an updated AGM Notice to shareholders today which contains certain non-substantive corrections.

The revised Notice of the Annual General Meeting ("AGM") is available on the Assura plc website at http://assuraplc.com/investor-relations/reports-and-presentations/  

In accordance with Listing Rule 9.6.1, a copy has also been submitted to the Financial Conduct Authority via the National Storage Mechanism and will be available for viewing shortly at https://data.fca.org.uk/#/nsm/nationalstoragemechanism 

- Ends -

For further information, please contact:

Assura plc:

Orla Ball, Company Secretary

David Purcell, Head of Financial Reporting
Tel: 01925 420 680

Email: [email protected]
Finsbury:

Gordon Simpson

James Thompson
Tel: 0207 251 3801

Email: [email protected]

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2020, Assura's property portfolio was valued at £2,139 million.

Further information is available at www.assuraplc.com 

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

NOAUUSRRRSUNAAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.